NCT06197204
- Conditions
- Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +4 more
- Locations
-
- Hopital Saint Louis Paris, France
Clinical trial condition
Histiocytosis, Langerhans-Cell
Explore clinical trials studying Histiocytosis, Langerhans-Cell. Study availability and eligibility vary by location and protocol.
5 public trials
2 recruiting studies
Histiocytosis, Langerhans-Cell trial results
Recruiting
Adult Pulmonary Langerhans Cell Histiocytosis: a National Registry-based Prospective Cohort Study
NCT04665674
- Conditions
- Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis Pulmonary, +5 more
- Locations
-
- French national reference centre for Histiocytoses Paris, France
Enrolling by Invitation
Adebrelimab Combined With Trametinib in the Treatment of Refractory Recurrent Langerhans Cell Histiocytosis in Children and Adolescents
NCT06902792
- Conditions
- Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +4 more
- Locations
-
- Second Affiliated Hospital of Wenzhou Medical University Wenzhou, Zhejiang, China
NCT00048373
- Conditions
- Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +4 more
- Locations
-
- Texas Children's Hospital Houston, Texas, United States
Active, Not Recruiting
Inherited Genetic Susceptibility in Langerhans Cell Histiocytosis (LCH)
NCT04100408
- Conditions
- Hemic and Lymphatic Diseases, Histiocytosis, Histiocytosis, Langerhans-Cell, +4 more
- Locations
-
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center Houston, Texas, United States